Johannesburg – The Phase II clinical study conducted in South Africa confirmed that the TAT therapeutic vaccine against HIV / AIDS can improve HIV treatments available today. The results are published in the peer-reviewed open access journal Retrovirology, one of the most influential journals in the field of HIV / AIDS. The vaccine was developed by CNAIDS (National Aids Centre) directed by Dr. Barbara Ensoli in the laboratories of the Superior Institute. (9Colonne)
